Back to Search
SUNITA TALEGAONKAR, M.D.
M.D.
Pediatrics Physician
NPI: 1407975246Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
0101054625(VA)
Research & Publications (20)
Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.
PMID 19647803·Drug Discov Today·2009
6-review
Enhanced transdermal drug delivery techniques: an extensive review of patents.
PMID 19519571·Recent Pat Drug Deliv Formul·2009
6-review
Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.
PMID 19470292·J Pharm Pharm Sci·2009
8-other
Nanoemulsion components screening and selection: a technical note.
PMID 19148761·AAPS PharmSciTech·2009
8-other
Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats.
PMID 19135530·Eur J Pharm Sci·2009
7-preclinical
Microemulsions as a surrogate carrier for dermal drug delivery.
PMID 19016057·Drug Dev Ind Pharm·2009
6-review
Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote.
PMID 18799362·Nanomedicine·2009
3-trial
Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
PMID 18720200·J Microencapsul·2009
7-preclinical
Buccoadhesive drug delivery systems--extensive review on recent patents.
PMID 19075906·Recent Pat Drug Deliv Formul·2008
6-review
Development and validation of reversed phase liquid chromatographic method utilizing ultraviolet detection for quantification of irinotecan (CPT-11) and its active metabolite, SN-38, in rat plasma and bile samples: application to pharmacokinetic studies.
PMID 18761148·Talanta·2008
4-observational
Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.
PMID 18619980·Life Sci·2008
7-preclinical
Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs.
PMID 18540836·Crit Rev Ther Drug Carrier Syst·2008
6-review
Transdermal therapeutic system of enalapril maleate using piperidine as penetration enhancer.
PMID 18393818·Curr Drug Deliv·2008
7-preclinical
Feasibility of proniosomes-based transdermal delivery of frusemide: formulation optimization and pharmacotechnical evaluation.
PMID 18379906·Pharm Dev Technol·2008
7-preclinical
Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation.
PMID 17983737·Eur J Pharm Biopharm·2008
8-other
Emerging role of microemulsions in cosmetics.
PMID 19075913·Recent Pat Drug Deliv Formul·2008
6-review
Microemulsions: a novel approach to enhanced drug delivery.
PMID 19075911·Recent Pat Drug Deliv Formul·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 430 CLAIRMONT CT, SUITE 211
COLONIAL HEIGHTS, VA 23834 - Phone
- (804) 526-0346
Quick Facts
- NPI
- 1407975246
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile